Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CATEQUENTINIB vs CEFDINIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CATEQUENTINIB vs CEFDINIR: Safety Overview

Metric CATEQUENTINIB CEFDINIR
Total FAERS Reports 324 1,627
Deaths Reported 44 35
Death Rate 13.6% 2.2%
Hospitalizations 115 262
Average Patient Age 57.2 yrs 37.8 yrs
% Female Patients 38.7% 65.6%
FDA Approval Date N/A Apr 6, 2007
Manufacturer N/A Sandoz Inc
Route N/A ORAL
Marketing Status N/A Discontinued